SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:umu-15281"
 

Sökning: id:"swepub:oai:DiVA.org:umu-15281" > Polymorphisms of me...

Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer : a nested case-control study

Van Guelpen, Bethany (författare)
Umeå universitet,Patologi
Wirén, Sara, 1981- (författare)
Umeå universitet,Urologi och andrologi
Bergh, Anders (författare)
Umeå universitet,Patologi
visa fler...
Hallmans, Göran (författare)
Umeå universitet,Näringsforskning
Stattin, Pär (författare)
Umeå universitet,Urologi och andrologi
Hultdin, Johan (författare)
Umeå universitet,Klinisk kemi
visa färre...
 (creator_code:org_t)
Lippincott Williams & Wilkins, 2006
2006
Engelska.
Ingår i: European Journal of Cancer Prevention. - : Lippincott Williams & Wilkins. - 0959-8278 .- 1473-5709. ; 15:1, s. 46-50
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • It has been proposed that folate and polymorphisms of the enzyme methylenetetrahydrofolate reductase (MTHFR), which regulates influx of folate from DNA synthesis and repair to methylation reactions, are involved in the aetiology of cancer. To relate the MTHFR 677C→T and 1298A→C polymorphisms to the risk of prostate cancer, taking into consideration prospective plasma levels of folate, vitamin B12 and homocysteine. The design was a case-control study of 223 prostate cancer cases and 435 matched controls nested within the population-based Northern Sweden Health and Disease Cohort. Neither the MTHFR 677C→T nor the MTHFR 1298A→C polymorphism was statistically significantly associated with the risk of prostate cancer in univariate analysis by conditional logistic regression. After adjustment for MTHFR 1298A→C, plasma folate, vitamin B12, homocysteine, body mass index and smoking, the odds ratios were, for the 677 CT genotype, 1.52 [95% confidence interval (CI) 1.02-2.26], and for TT, 0.91 (95% CI 0.41-2.04). Our previously reported observation of a possible increase in the risk of prostate cancer at high plasma folate levels was attributable in this study to subjects having the MTHFR 677C→T polymorphism. We found that the MTHFR 677C→T polymorphism is not likely to have a major role in the development of prostate cancer, although it may possibly increase the risk in combination with high plasma folate levels. Further investigation in larger studies is warranted.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

Adult
Case-Control Studies
Folic Acid/blood
Genotype
Homocysteine/blood
Humans
Male
Methylenetetrahydrofolate Reductase (NADPH2)/*genetics
Middle Aged
Odds Ratio
Polymorphism; Genetic
Prospective Studies
Prostatic Neoplasms/*genetics
Risk
Sweden
Vitamin B 12/blood

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy